Enterprise Associates 14, L... Net Worth

The estimated Net Worth of Enterprise Associates 14, L... is at least 22.9 百万$ dollars as of 21 January 2022. Enterprise L owns over 134,558 units of Imara Inc stock worth over 20,891,398$ and over the last 5 years Enterprise sold IMRA stock worth over 2,028,075$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Enterprise L IMRA stock SEC Form 4 insiders trading

Enterprise has made over 6 trades of the Imara Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Enterprise sold 134,558 units of IMRA stock worth 201,837$ on 21 January 2022.

The largest trade Enterprise's ever made was selling 420,000 units of Imara Inc stock on 20 May 2020 worth over 1,537,200$. On average, Enterprise trades about 114,808 units every 102 days since 2020. As of 21 January 2022 Enterprise still owns at least 3,305,601 units of Imara Inc stock.

You can see the complete history of Enterprise L stock trades at the bottom of the page.

Insiders trading at Imara Inc

Over the last 5 years, insiders at Imara Inc have traded over 7,889,059$ worth of Imara Inc stock and bought 11,496,717 units worth 107,874,489$ . The most active insiders traders include David M Mott、Lundbeck A S H、Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of 1,965,179$. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth 46,028$.

What does Imara Inc do?

Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.

Complete history of Enterprise L stock trades at Surface Oncology Inc、Imara Inc

Imara Inc executives and stock owners

Imara Inc executives and other stock owners filed with the SEC include:

• Rahul D. Ballal,
  Chief Executive Officer
• Edward R. Conner,
  Director
• Enterprise Associates 14, L...,
  
• Springs Capital Management ...,
  
• Lundbeck A S H,
  10% owner
• City Capital Llc Bay City C...,
  
• Venture Investments, Llc Al...,
  10% owner
• Invest A/S Lundbeckfond,
  10% owner
• Bioscience Plc Arix Bioscie...,
  
• Capital Management, L.P.Ra ...,
  
• Advisors Llc Orbi Med Capit...,
  
• James G Mc Arthur,
  Director
• Carlbay City Capital Llc Ba...,
  
• Mette Kirstine Agger,
  Director
• David P Bonita,
  Director
• Barbara Dalton,
  Director
• Sara M. Nayeem,
  Director
• David M Mott,
  Director
• Inc Pfizer Ventures (Us) Ll...,
  
• Enterprise Associates 14, L...,
  
• Michael Gray,
  CFO & COO
• Kenneth Attie,
  SVP, CMO
• Laura A Williams,
  Director
• Carl Goldfischer,
  Director
• Mark Chin,
  Director
• Advisors Llc Orbi Med Capit...,
  
• Braden Michael Leonard,
  10% owner
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Enterprise Associates 14, L...,
  
• Capital Lp Commodore,
  10% owner